Back

Boryung to spin off ETC sales unit into wholly owned subsidiary

Verifying
  • Boryung will transfer its ETC sales and marketing business to Boryung Pharma Solution.
  • The subsidiary will have ₩56.95 billion in assets as of end-June 2026.
  • Shareholders will vote on October 28, 2026, before the January 4, 2027 launch.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.